BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 12192561)

  • 1. FDG-PET imaging in lung cancer: how sensitive is it for bronchioloalveolar carcinoma?
    Yap CS; Schiepers C; Fishbein MC; Phelps ME; Czernin J
    Eur J Nucl Med Mol Imaging; 2002 Sep; 29(9):1166-73. PubMed ID: 12192561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of bronchioloalveolar cancer by means of PET/CT and 18F-fluorocholine, and comparison with 18F-fluorodeoxyglucose.
    Balogova S; Huchet V; Kerrou K; Nataf V; Gutman F; Antoine M; Ruppert AM; Prignon A; Lavolée A; Montravers F; Mayaud C; Cadranel J; Talbot JN
    Nucl Med Commun; 2010 May; 31(5):389-97. PubMed ID: 20145579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical usefulness of the fluorodeoxyglucose (FDG)-PET maximal standardized uptake value (SUV) in combination with CT features for the differentiation of adenocarcinoma with a bronchioloalveolar carcinoma from other subtypes of non-small cell lung cancers.
    Sun JS; Park KJ; Sheen SS; Yoon JK; Yoon SN; Lee KB; Hwang SC
    Lung Cancer; 2009 Nov; 66(2):205-10. PubMed ID: 19203812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Accuracy of positron emission tomography with fluorine-18-fluoro-deoxyglucose].
    Hellwig D; Gröschel A; Rentz K; Sybrecht GW; Kirsch CM; Ukena D
    Pneumologie; 2001 Aug; 55(8):363-6. PubMed ID: 11505287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Positron emission tomography in relation to Noguchi's classification for diagnosis of peripheral non-small-cell lung cancer 2 cm or less in size.
    Tsunezuka Y; Shimizu Y; Tanaka N; Takayanagi T; Kawano M
    World J Surg; 2007 Feb; 31(2):314-7. PubMed ID: 17219276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Localized form of bronchioloalveolar carcinoma: FDG PET findings.
    Kim BT; Kim Y; Lee KS; Yoon SB; Cheon EM; Kwon OJ; Rhee CH; Han J; Shin MH
    AJR Am J Roentgenol; 1998 Apr; 170(4):935-9. PubMed ID: 9530038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluorine-18-FDG PET imaging is negative in bronchioloalveolar lung carcinoma.
    Higashi K; Ueda Y; Seki H; Yuasa K; Oguchi M; Noguchi T; Taniguchi M; Tonami H; Okimura T; Yamamoto I
    J Nucl Med; 1998 Jun; 39(6):1016-20. PubMed ID: 9627336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of [(18)F]FDG PET and (201)Tl SPECT in evaluation of pulmonary nodules.
    Higashi K; Ueda Y; Sakuma T; Seki H; Oguchi M; Taniguchi M; Taki S; Tonami H; Katsuda S; Yamamoto I
    J Nucl Med; 2001 Oct; 42(10):1489-96. PubMed ID: 11585862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of Glut-1 glucose transporter expression with.
    Higashi K; Ueda Y; Sakurai A; Wang XM; Xu L; Murakami M; Seki H; Oguchi M; Taki S; Nambu Y; Tonami H; Katsuda S; Yamamoto I
    Eur J Nucl Med; 2000 Dec; 27(12):1778-85. PubMed ID: 11189940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diagnostic value of (18)F-FDG PET/CT for solitary nodular-type bronchoalveolar carcinoma].
    Liu W; Li X; Quan J; Ouyang X; Zheng H
    Nan Fang Yi Ke Da Xue Xue Bao; 2013 Jan; 33(1):114-6. PubMed ID: 23353168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. False-negative PET scan with bronchioloalveolar carcinoma: an important diagnostic caveat.
    Awab A; Hamadani M; Peyton M; Brown B
    Am J Med Sci; 2007 Oct; 334(4):311-3. PubMed ID: 18030191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor fluoro-2-deoxy-D-glucose avidity on positron emission tomographic scan predicts mortality in patients with early-stage pure and mixed bronchioloalveolar carcinoma.
    Raz DJ; Odisho AY; Franc BL; Jablons DM
    J Thorac Cardiovasc Surg; 2006 Nov; 132(5):1189-95. PubMed ID: 17059942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosis and differentiation of bronchioloalveolar carcinoma from adenocarcinoma with bronchioloalveolar components with metabolic and anatomic characteristics using PET/CT.
    Goudarzi B; Jacene HA; Wahl RL
    J Nucl Med; 2008 Oct; 49(10):1585-92. PubMed ID: 18794276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synchronous bronchioloalveolar and squamous cell lung cancer with different 18F-FDG avidity on PET/CT.
    Derlin T; Clauditz TS; Quaas A; Habermann CR
    Clin Nucl Med; 2012 Oct; 37(10):e255-6. PubMed ID: 22899191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associations among bronchioloalveolar carcinoma components, positron emission tomographic and computed tomographic findings, and malignant behavior in small lung adenocarcinomas.
    Okada M; Tauchi S; Iwanaga K; Mimura T; Kitamura Y; Watanabe H; Adachi S; Sakuma T; Ohbayashi C
    J Thorac Cardiovasc Surg; 2007 Jun; 133(6):1448-54. PubMed ID: 17532938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of a dual-head coincidence camera and 18F-FDG for detection and nodal staging of non-small cell lung cancer: accuracy as determined by 2 independent observers.
    Stevens H; Bakker PF; Schlösser NJ; van Rijk PP; de Klerk JM
    J Nucl Med; 2003 Mar; 44(3):336-40. PubMed ID: 12620997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FDG-PET and CT features of non-small cell lung cancer based on tumor type.
    Aquino SL; Halpern EF; Kuester LB; Fischman AJ
    Int J Mol Med; 2007 Mar; 19(3):495-9. PubMed ID: 17273799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bronchioloalveolar carcinoma and lung adenocarcinoma: the clinical importance and research relevance of the 2004 World Health Organization pathologic criteria.
    Travis WD; Garg K; Franklin WA; Wistuba II; Sabloff B; Noguchi M; Kakinuma R; Zakowski M; Ginsberg M; Padera R; Jacobson F; Johnson BE; Hirsch F; Brambilla E; Flieder DB; Geisinger KR; Thunnissen F; Kerr K; Yankelevitz D; Franks TJ; Galvin JR; Henderson DW; Nicholson AG; Hasleton PS; Roggli V; Tsao MS; Cappuzzo F; Vazquez M
    J Thorac Oncol; 2006 Nov; 1(9 Suppl):S13-9. PubMed ID: 17409995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The application of 18F-fluorodeoxyglucose positron emission tomography in the diagnosis and staging of lung cancer].
    Xu HF; Liu Y; Zhang JH; Zhou RS; Zhou FH; Yuan MH
    Zhonghua Jie He He Hu Xi Za Zhi; 2005 Feb; 28(2):108-11. PubMed ID: 15854393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Value of positron emission tomography for lung cancer staging.
    Albes JM; Dohmen BM; Schott U; Schülen E; Wehrmann M; Ziemer G
    Eur J Surg Oncol; 2002 Feb; 28(1):55-62. PubMed ID: 11869015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.